APO RESEARCH · REPORT
Methotrexate
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Product & engineering
Understand the product.
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Selected research
Market Analysis & Forecast
Global Methotrexate Market Analysis and Forecast 2026-2032
Market perspective
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
Read the full market overview
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
This report presents an overview of global market for Methotrexate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Methotrexate, also provides the sales of main regions and countries. Of the upcoming market potential for Methotrexate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methotrexate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Methotrexate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Methotrexate sales, projected growth trends, production technology, application and end-user industry.
Methotrexate Segment by Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Methotrexate Segment by Type
Methotrexate for Injection
Methotrexate Tablets
Methotrexate Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
Methotrexate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Methotrexate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methotrexate sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate for Injection
- Methotrexate Tablets
Applications
- Used for Cancers
- Used for Rheumatoid Arthritis
- Used for Other Diseases
Companies covered
- Teva Pharmaceutical Industries
- Qualitestrx (DAVA Pharmaceuticals)
- Pfizer (Hospira)
- Roxane Laboratories
- Sine
- Maoxiang
- LingNan Pharmaceutical
- Powerdone
- Huiyu
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Methotrexate Market by Type
- 1.2.1 Global Methotrexate Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Methotrexate for Injection
- 1.2.3 Methotrexate Tablets
- 1.3 Methotrexate Market by Application
- 1.3.1 Global Methotrexate Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Used for Cancers
- 1.3.3 Used for Rheumatoid Arthritis
- 1.3.4 Used for Other Diseases
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Methotrexate Market Dynamics
- 2.1 Methotrexate Industry Trends
- 2.2 Methotrexate Industry Drivers
- 2.3 Methotrexate Industry Opportunities and Challenges
- 2.4 Methotrexate Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Methotrexate Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Methotrexate Revenue by Region
- 3.2.1 Global Methotrexate Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Methotrexate Revenue by Region (2021-2026)
- 3.2.3 Global Methotrexate Revenue by Region (2027-2032)
- 3.2.4 Global Methotrexate Revenue Market Share by Region (2021-2032)
- 3.3 Global Methotrexate Sales Estimates and Forecasts 2021-2032
- 3.4 Global Methotrexate Sales by Region
- 3.4.1 Global Methotrexate Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Methotrexate Sales by Region (2021-2026)
- 3.4.3 Global Methotrexate Sales by Region (2027-2032)
- 3.4.4 Global Methotrexate Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Methotrexate Revenue by Manufacturers
- 4.1.1 Global Methotrexate Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Methotrexate Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Methotrexate Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Methotrexate Sales by Manufacturers
- 4.2.1 Global Methotrexate Sales by Manufacturers (2021-2026)
- 4.2.2 Global Methotrexate Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Methotrexate Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Methotrexate Sales Price by Manufacturers (2021-2026)
- 4.4 Global Methotrexate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Methotrexate Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Methotrexate Manufacturers, Product Type & Application
- 4.7 Global Methotrexate Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Methotrexate Market CR5 and HHI
- 4.8.2 2025 Methotrexate Tier 1, Tier 2, and Tier 3
5 Methotrexate Market by Type
- 5.1 Global Methotrexate Revenue by Type
- 5.1.1 Global Methotrexate Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Methotrexate Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Methotrexate Revenue Market Share by Type (2021-2032)
- 5.2 Global Methotrexate Sales by Type
- 5.2.1 Global Methotrexate Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Methotrexate Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Methotrexate Sales Market Share by Type (2021-2032)
- 5.3 Global Methotrexate Price by Type
6 Methotrexate Market by Application
- 6.1 Global Methotrexate Revenue by Application
- 6.1.1 Global Methotrexate Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Methotrexate Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Methotrexate Revenue Market Share by Application (2021-2032)
- 6.2 Global Methotrexate Sales by Application
- 6.2.1 Global Methotrexate Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Methotrexate Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Methotrexate Sales Market Share by Application (2021-2032)
- 6.3 Global Methotrexate Price by Application
7 Company Profiles
- 7.1 Teva Pharmaceutical Industries
- 7.1.1 Teva Pharmaceutical Industries Company Information
- 7.1.2 Teva Pharmaceutical Industries Business Overview
- 7.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Pharmaceutical Industries Methotrexate Product Portfolio
- 7.1.5 Teva Pharmaceutical Industries Recent Developments
- 7.2 Qualitestrx (DAVA Pharmaceuticals)
- 7.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
- 7.2.2 Qualitestrx (DAVA Pharmaceuticals) Business Overview
- 7.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Portfolio
- 7.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Developments
- 7.3 Pfizer (Hospira)
- 7.3.1 Pfizer (Hospira) Company Information
- 7.3.2 Pfizer (Hospira) Business Overview
- 7.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer (Hospira) Methotrexate Product Portfolio
- 7.3.5 Pfizer (Hospira) Recent Developments
- 7.4 Roxane Laboratories
- 7.4.1 Roxane Laboratories Company Information
- 7.4.2 Roxane Laboratories Business Overview
- 7.4.3 Roxane Laboratories Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Roxane Laboratories Methotrexate Product Portfolio
- 7.4.5 Roxane Laboratories Recent Developments
- 7.5 Sine
- 7.5.1 Sine Company Information
- 7.5.2 Sine Business Overview
- 7.5.3 Sine Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sine Methotrexate Product Portfolio
- 7.5.5 Sine Recent Developments
- 7.6 Maoxiang
- 7.6.1 Maoxiang Company Information
- 7.6.2 Maoxiang Business Overview
- 7.6.3 Maoxiang Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Maoxiang Methotrexate Product Portfolio
- 7.6.5 Maoxiang Recent Developments
- 7.7 LingNan Pharmaceutical
- 7.7.1 LingNan Pharmaceutical Company Information
- 7.7.2 LingNan Pharmaceutical Business Overview
- 7.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 LingNan Pharmaceutical Methotrexate Product Portfolio
- 7.7.5 LingNan Pharmaceutical Recent Developments
- 7.8 Powerdone
- 7.8.1 Powerdone Company Information
- 7.8.2 Powerdone Business Overview
- 7.8.3 Powerdone Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Powerdone Methotrexate Product Portfolio
- 7.8.5 Powerdone Recent Developments
- 7.9 Huiyu
- 7.9.1 Huiyu Company Information
- 7.9.2 Huiyu Business Overview
- 7.9.3 Huiyu Methotrexate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Huiyu Methotrexate Product Portfolio
- 7.9.5 Huiyu Recent Developments
8 North America
- 8.1 North America Methotrexate Market Size by Type
- 8.1.1 North America Methotrexate Revenue by Type (2021-2032)
- 8.1.2 North America Methotrexate Sales by Type (2021-2032)
- 8.1.3 North America Methotrexate Price by Type (2021-2032)
- 8.2 North America Methotrexate Market Size by Application
- 8.2.1 North America Methotrexate Revenue by Application (2021-2032)
- 8.2.2 North America Methotrexate Sales by Application (2021-2032)
- 8.2.3 North America Methotrexate Price by Application (2021-2032)
- 8.3 North America Methotrexate Market Size by Country
- 8.3.1 North America Methotrexate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Methotrexate Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Methotrexate Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Methotrexate Market Size by Type
- 9.1.1 Europe Methotrexate Revenue by Type (2021-2032)
- 9.1.2 Europe Methotrexate Sales by Type (2021-2032)
- 9.1.3 Europe Methotrexate Price by Type (2021-2032)
- 9.2 Europe Methotrexate Market Size by Application
- 9.2.1 Europe Methotrexate Revenue by Application (2021-2032)
- 9.2.2 Europe Methotrexate Sales by Application (2021-2032)
- 9.2.3 Europe Methotrexate Price by Application (2021-2032)
- 9.3 Europe Methotrexate Market Size by Country
- 9.3.1 Europe Methotrexate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Methotrexate Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Methotrexate Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Methotrexate Market Size by Type
- 10.1.1 China Methotrexate Revenue by Type (2021-2032)
- 10.1.2 China Methotrexate Sales by Type (2021-2032)
- 10.1.3 China Methotrexate Price by Type (2021-2032)
- 10.2 China Methotrexate Market Size by Application
- 10.2.1 China Methotrexate Revenue by Application (2021-2032)
- 10.2.2 China Methotrexate Sales by Application (2021-2032)
- 10.2.3 China Methotrexate Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Methotrexate Market Size by Type
- 11.1.1 Asia Methotrexate Revenue by Type (2021-2032)
- 11.1.2 Asia Methotrexate Sales by Type (2021-2032)
- 11.1.3 Asia Methotrexate Price by Type (2021-2032)
- 11.2 Asia Methotrexate Market Size by Application
- 11.2.1 Asia Methotrexate Revenue by Application (2021-2032)
- 11.2.2 Asia Methotrexate Sales by Application (2021-2032)
- 11.2.3 Asia Methotrexate Price by Application (2021-2032)
- 11.3 Asia Methotrexate Market Size by Country
- 11.3.1 Asia Methotrexate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Methotrexate Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Methotrexate Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Methotrexate Market Size by Type
- 12.1.1 SAMEA Methotrexate Revenue by Type (2021-2032)
- 12.1.2 SAMEA Methotrexate Sales by Type (2021-2032)
- 12.1.3 SAMEA Methotrexate Price by Type (2021-2032)
- 12.2 SAMEA Methotrexate Market Size by Application
- 12.2.1 SAMEA Methotrexate Revenue by Application (2021-2032)
- 12.2.2 SAMEA Methotrexate Sales by Application (2021-2032)
- 12.2.3 SAMEA Methotrexate Price by Application (2021-2032)
- 12.3 SAMEA Methotrexate Market Size by Country
- 12.3.1 SAMEA Methotrexate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Methotrexate Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Methotrexate Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Methotrexate Value Chain Analysis
- 13.1.1 Methotrexate Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Methotrexate Production Mode & Process
- 13.2 Methotrexate Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Methotrexate Distributors
- 13.2.3 Methotrexate Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst